← back to search

Margaux A. Morrison

University of Utah · US
Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Imaging and Analysis, Ophthalmology and Visual Impairment Studies, and Glaucoma and retinal disorders.
h-index
25
citations
4,091
works
50
NIH funding
primary concept
email

Recent publications

Genome-wide association analyses identify distinct genetic architectures for age-related macular degeneration across ancestries
Nature Genetics 2024cited by 35position: middledoi
A transcriptome-wide association study based on 27 tissues identifies 106 genes potentially relevant for disease pathology in age-related macular degeneration
Scientific Reports 2020cited by 63position: middledoi
ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder
Genetics in Medicine 2019cited by 65position: middledoi
Prevalence and correlates of bleeding and emotional harms in a national US sample of patients with venous thromboembolism: A cross-sectional structural equation model
Thrombosis Research 2018cited by 28position: middledoi
Genetics of age-related macular degeneration (AMD)
Human Molecular Genetics 2017cited by 175position: middledoi
Retinopathy of prematurity: A comprehensive risk analysis for prevention and prediction of disease
PLoS ONE 2017cited by 52position: middledoi
Genetics of age-related macular degeneration (AMD)
Human Molecular Genetics 2017cited by 49position: middledoi
Factors predicting self-reported medication low adherence in a large sample of adults in the US general population: a cross-sectional study
BMJ Open 2017cited by 34position: middledoi
ER stress-induced aggresome trafficking of HtrA1 protects against proteotoxicity
Journal of Molecular Cell Biology 2017cited by 14position: middledoi
Adherence to Glaucoma Medications Over 12 Months in Two US Community Pharmacy Chains
Journal of Clinical Medicine 2016cited by 36position: middledoi
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
Nature Genetics 2015cited by 1,600position: middledoi
Analysis of Genetic and Environmental Risk Factors and Their Interactions in Korean Patients with Age-Related Macular Degeneration
PLoS ONE 2015cited by 55position: middledoi
Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea
Ophthalmology 2015cited by 23position: middledoi
Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration
Human Molecular Genetics 2014cited by 62position: middledoi
Genetic Variants Associated With Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
Investigative Ophthalmology & Visual Science 2014cited by 62position: middledoi
Seven new loci associated with age-related macular degeneration
Nature Genetics 2013cited by 799position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Margaret M. DeAngelis · University of Utah9 papers (2014–2018)Michael Feehan · Oracle (United States)3 papers (2016–2018)Ivana K. Kim · Massachusetts Eye and Ear Infirmary3 papers (2015–2017)Leah A. Owen · University of Utah3 papers (2017–2017)Mark A. Munger · University of Utah3 papers (2016–2018)Mingyao Li · Guangdong Testing Institute for Product Quality Supervision2 papers (2017–2017)Sudha K. Iyengar · Louis Stokes Cleveland VA Medical Center2 papers (2017–2017)Lindsay A. Farrer · Boston University2 papers (2017–2017)Albert T. Vitale · University of Utah2 papers (2017–2017)Akbar Shakoor · University of Utah2 papers (2017–2017)Denise J. Morgan · University of Utah2 papers (2017–2017) · 1 papers (2016–2016)Jeff Murray · University of Iowa1 papers (2014–2014)Terri L. Young · University of Wisconsin System1 papers (2014–2014)Joseph A. Marsh · Hospital for Sick Children1 papers (2017–2017)Daniel O. Clegg · Texas Tech University Health Sciences Center1 papers (2016–2016)Gregory T. Jones · University of Otago1 papers (2016–2016)Magali Saint‐Geniez · Novartis (Switzerland)1 papers (2017–2017) · 1 papers (2015–2015)Michael Walsh · Cleveland Clinic1 papers (2018–2018)